Capital International Investors Xenon Pharmaceuticals Inc. Transaction History

Capital International Investors

$557 Billion
Q2 2025

A detailed history of Capital International Investors transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Capital International Investors holds 3,181,549 shares of XENE stock, worth $115 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,181,549

Previous 3,088,730 3.01%

Holding current value

$115 Million

Previous $104 Million 3.9%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$28.23 - $38.37 $2.62 Million - $3.56 Million	92,819 Added 3.01%	3,181,549 $99.6 Million
Q1 2025 May 12, 2025	BUY	$33.55 - $40.74 $18.2 Million - $22.1 Million	541,520 Added 21.26%	3,088,730 $104 Million
Q4 2024 Feb 13, 2025	SELL	$38.14 - $45.74 $1.3 Million - $1.55 Million	-33,962 Reduced 1.32%	2,547,210 $99.9 Million
Q3 2024 Nov 13, 2024	BUY	$36.12 - $43.96 $3.8 Million - $4.63 Million	105,313 Added 4.25%	2,581,172 $102 Million
Q1 2024 May 14, 2024	BUY	$42.66 - $50.04 $860,708 - $1.01 Million	20,176 Added 0.82%	2,475,859 $107 Million
Q4 2023 Feb 13, 2024	BUY	$28.7 - $46.46 $254,368 - $411,774	8,863 Added 0.36%	2,455,683 $113 Million
Q3 2023 Nov 13, 2023	BUY	$34.16 - $39.73 $4.26 Million - $4.96 Million	124,829 Added 5.38%	2,446,820 $83.6 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $7.44 Million - $8.97 Million	222,412 Added 10.59%	2,321,991 $83.1 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $15.1 Million - $18 Million	457,071 Added 27.83%	2,099,579 $82.8 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $1.85 Million - $2.39 Million	60,000 Added 3.79%	1,642,508 $59.3 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $18.2 Million - $25.1 Million	714,211 Added 82.25%	1,582,508 $48.1 Million
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $4.7 Million - $6.21 Million	-187,429 Reduced 17.75%	868,297 $26.5 Million
Q1 2019 May 15, 2019	BUY	$6.39 - $10.42 $756,103 - $1.23 Million	118,326 Added 12.62%	1,055,726 $10.7 Million
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $8.44 Million - $14 Million	937,400 New	937,400 $12.4 Million

Others Institutions Holding XENE

# of Institutions

223

Shares Held

72.2M

Call Options Held

435K

Put Options Held

207K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.24B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Xenon Pharmaceuticals Inc. Transaction History